Open research questions in Pharmacological Effects and Toxicity Studies
110 gap statements mined from Pharmacological Effects and Toxicity Studies papers in our 7.9M-paper local library, which holds 1,029 papers on the topic — drawn mostly from each paper's own stated research gap, future-work, challenge and limitation notes, and its abstract. The ones listed below are a selection still marked open; each names the study that raised it, with a DOI link where the paper has one.
Choosing where to publish on Pharmacological Effects and Toxicity Studies? See the ranked Medicine journals.
What the literature leaves open
However, this mechanism does not account for all the effects described on bone health associated with ASMs. The effects of CBZ on bone health and the endocrine system are not well understood. Because there is insufficient evidence regarding the effect of CBZ on bone metabolism in our region, addressing this knowledge gap is particularly important.
Long-term effects of carbamazepine on bone-related biochemical markers in patients with epilepsy · 2026 · DOIOur findings reveal well-established hormonal and lipid pathways alongside emerging but underexplored genetic mechanisms, highlighting key knowledge gaps that warrant further investigation.
There is a need for safer and more effective treatment options for preterm neonates with seizures. The current treatment options have limitations and potential adverse effects. There is a lack of randomized controlled trials comparing the effectiveness of different treatment options for preterm neonates with seizures.
Evidence remains inconclusive on whether paternal valproate exposure during spermatogenesis is associated with adverse offspring outcomes, with findings lacking beyond Nordic countries.
Sodium valproate (SV) is a widely used anti-epileptic drug with well-established reproductive and teratogenic effects, yet its impact on the developing prepubertal reproductive system remains poorly understood.
The electroclinical spectrum of ictal lingual phenomenology remains incompletely defined. There are only a few video-documented cases of lingual seizures. The symptomatogenic network underlying lingual seizures is more complex than a strictly somatotopic representation of the tongue within the primary motor cortex.
Tongue tied by blood: a video-documented case of lingual focal motor status epilepticus · 2026 · DOIThe influence of anti-seizure medications on hormone metabolism and function, particularly mechanisms involving the hypothalamic-pituitary axis, should be carefully considered. There is a need to evaluate the effects of levetiracetam on thyroid function and volume in pediatric epileptic patients.
Evaluation of thyroid function and thyroid volume in pediatric epileptic patients receiving levetiracetam monotherapy · 2026 · DOIThe need to control for confounding variables, such as antiseizure medication exposure and disease duration. The difficulty of interpreting correlation analyses due to the complexity of thyroid-metabolic interactions.
Thyroid-metabolic interactions in pediatric epilepsy: insights from central sensitivity indices and peripheral hormone markers · 2026 · DOIFolic acid (FA) is essential for fetal development, while the benefits and optimal dose in pregnant women with epilepsy (PWWE) remain unclear.
Folic acid supplementation and prevention of adverse offspring outcomes among women with epilepsy: An observational study · 2026 · DOIAlthough congenital anomalies and neurodevelopmental impairments are well described in those affected by in utero VPA exposure, limited data are available regarding the physical health impacts.
Beyond congenital anomalies, the impact of sodium valproate exposure in utero on long‐term health and well‐being: A contribution from the ConcePTION project · 2026 · DOIAlthough published studies have illuminated much about VPA's neurotoxic, teratogenic effects, a lack of standardization in testing methodologies renders making direct comparisons between the results of different studies challenging.
In vitro models of valproic acid to assess neurodevelopmental toxicity: A scoping review · 2025 · DOIThere are limited therapeutic options for traumatic brain injury. Clinical studies with hormone, antioxidant or immunosuppressive approaches have been unsuccessful or only moderately successful. The interconnection of neuroprotection, metabolism, inflammation and REST/NRSF after TBI is not well understood.
Valproic Acid Treatment after Traumatic Brain Injury in Mice Alleviates Neuronal Death and Inflammation in Association with Increased Plasma Lysophosphatidylcholines · 2024 · DOIOne challenge is the complexity of redox homeostasis and its regulation in human blood. Another challenge is the need to control for daily dosage regimes and other factors that may affect redox parameters.
Little is known about the impact of anti-seizure medications on redox homeostasis. There is a need to investigate the effects of long-term anti-seizure medications on antioxidant enzymes in human blood.
Although structured chart review and adverse reporting systems were used, events may still be underreported.
Limited reliable biomarkers for individualized prediction of valproic acid efficacy and hepatotoxicity. Substantial interindividual variability exists in therapeutic efficacy and hepatotoxicity during valproic acid treatment.
Integrated metabolomic and pharmacogenomic analysis for prediction of valproic acid efficacy and hepatotoxicity in pediatric epilepsy · 2026 · DOIThe odds of spontaneous miscarriage, spontaneous fetal loss, elective cesarean section, 5-minute APGAR score <7, and admission to the neonatal intensive care unit were significantly greater in ASM-exposed than in unexposed pregnancies in women with the same indications, but the possible confounding effect of between-group differences in disease severity could not be assessed.
Risk of Adverse Pregnancy Outcomes Associated With Antiseizure Medications and Their Indications · 2025 · DOIParticipants were divided into four subgroups based on ASM exposure: Subgroup 1, first trimester (T1) exposure (first 12 weeks); Subgroup 2, exposure limited to the first 140 days; Subgroup 3, exposure only after day 141; Subgroup 4, continuous exposure.
Fetal outcomes of antiseizure medication use during pregnancy: A nationwide retrospective cohort study · 2025 · DOIWe here demonstrate that exposure to ETI during pregnancy is associated with observable molecular changes in the brain lipidome, which are not likely limited to the inhibition of DEGS.
Exposure of dams to Elexacaftor/ Tezacaftor/Ivacaftor during pregnancy and breastfeeding induces reversible alterations in newborn wild type CD-1 mice · 2025 · DOINeurodevelopmental effects of fetal antiseizure medication (ASM) exposure on creativity and executive functions are poorly understood.
Association of Prenatal Exposure to Antiseizure Medications With Creative and Executive Function at Age 4.5 Years · 2024 · DOIInvestigate the long-term effects of epilepsy and its treatment on thyroid hormone metabolism, - Examine the relationship between thyroid hormone metabolism and seizure control, - Explore the potential benefits of thyroid hormone regulation in patients with epilepsy, - Study the effects of different antiseizure medications on thyroid hormone…
Thyroid-metabolic interactions in pediatric epilepsy: insights from central sensitivity indices and peripheral hormone markers · 2026 · DOIFurther studies are needed to validate the findings and to explore the potential of multi-omics approaches in individualized precision treatment, - Investigation of the underlying mechanisms of VPA therapeutic efficacy and hepatotoxicity is necessary, - Development of more accurate and reliable prediction models for VPA treatment outcomes…
Integrated metabolomic and pharmacogenomic analysis for prediction of valproic acid efficacy and hepatotoxicity in pediatric epilepsy · 2026 · DOIFurther studies could investigate the safety and efficacy of undiluted IVP VPA in different patient populations, - Studies could examine the long-term effects of rapid VPA administration, - Research could explore the optimal dosing and administration protocols for IVP…
Further studies are needed to investigate the mechanisms by which VPA exerts its neuroprotective effects, - Research on the long-term effects of VPA treatment after TBI is necessary, - Studies on the potential therapeutic applications of VPA in human TBI patients should be…
Valproic Acid Treatment after Traumatic Brain Injury in Mice Alleviates Neuronal Death and Inflammation in Association with Increased Plasma Lysophosphatidylcholines · 2024 · DOIFurther study on the use of drug sensitisers to improve therapeutic index, - Investigation of the potential benefits and risks of combining drugs, - Research on the application of drug repurposing in cancer…
Most-cited papers in Pharmacological Effects and Toxicity Studies
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS · Acta Psychiatrica Scandinavica · 1970 · 2,571 citations
- Risk of Death With Atypical Antipsychotic Drug Treatment for Dementia · JAMA · 2005 · 1,415 citations
- Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism · JAMA · 2013 · 1,174 citations
- Lower Risk for Tardive Dyskinesia Associated With Second-Generation Antipsychotics: A Systematic Review of 1-Year Studies · American Journal of Psychiatry · 2004 · 563 citations
- In utero exposure to valproic acid and autism — A current review of clinical and animal studies · Neurotoxicology and Teratology · 2013 · 372 citations
- Abuse and Misuse of Pregabalin and Gabapentin · Drugs · 2017 · 349 citations
- Guidelines for the Rational Use of Benzodiazepines · Drugs · 1994 · 318 citations
- Efficacy and Tolerability of Carbamazepine for Agitation and Aggression in Dementia · American Journal of Psychiatry · 1998 · 310 citations
- Controlled Study of Haloperidol, Pimozide, and Placebo for the Treatment of Gilles de la Tourette's Syndrome · Archives of General Psychiatry · 1989 · 302 citations
- A Randomized Evaluation of the Effects of Six Antipsychotic Agents on QTc, In the Absence and Presence of Metabolic Inhibition · Journal of Clinical Psychopharmacology · 2004 · 295 citations
Most recent work
- Risk of neurodevelopmental disorders associated with paternal use of valproate during spermatogenesis · Journal of Neurology Neurosurgery & Psychiatry · 2026
- Effect of carbamazepine on the pharmacokinetics of vepdegestrant, a PROteolysis TArgeting Chimera estrogen receptor degrader, in healthy adults · British Journal of Clinical Pharmacology · 2026
- Women with epilepsy: Evidence‐based counseling across the lifespan · Epilepsia · 2026
- Antiseizure Medication Polytherapies During Pregnancy and the Risk of Congenital Malformations · Neurology · 2026
- The outcomes of consecutive pregnancies in Australian women with epilepsy · Epileptic Disorders · 2026
- The Rationale for, and Use of, Benzodiazepines in Cardiac Conditions · Psychiatric Annals · 2026
- Neuroleptic malignant syndrome precipitated by chlorpromazine: a case report · Journal of Medical Case Reports · 2026
- Transcription Factor Binding and Individual Genetic Risk of Valproate Teratogenicity · Neurology · 2026
- Intrauterine exposure to maternal diabetes and the risk of developing epilepsy in children: a national cohort study of 2.3 million children · BMC Medicine · 2026
- The neurological significance of folate deficiency in women with epilepsy · Brain · 2026
Find a gap in your own Pharmacological Effects and Toxicity Studies sub-topic
This page shows what the Pharmacological Effects and Toxicity Studies literature already flags as unresolved. To narrow it to your specific question, search the Research Gap Finder: the search is free with a free account and lists the papers closest to your topic first. Unlocking that topic (50 credits, charged once) fills the comparison table from our 7.9M-paper local library and writes the gaps from its rows.
Open the Research Gap Finder →